Casten Richard S 4
4 · Baudax Bio, Inc. · Filed Mar 10, 2021
Insider Transaction Report
Form 4
Baudax Bio, Inc.BXRX
Casten Richard S
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-08+15,000→ 15,000 totalExercise: $1.21Exp: 2031-03-08→ Common Stock (15,000 underlying) - Award
Common Stock
2021-03-08+15,000→ 15,000 total - Award
Common Stock
2021-03-08+85,000→ 100,000 total - Award
Stock Option (right to buy)
2021-03-08+255,000→ 255,000 totalExercise: $1.21Exp: 2031-03-08→ Common Stock (255,000 underlying)
Footnotes (4)
- [F1]These restricted stock units will vest in full on December 31, 2021, subject to continued service with the Company.
- [F2]These restricted stock units will vest in four equal annual installments beginning on March 8, 2022, subject to continued service with the Company.
- [F3]The stock option will vest in full on December 31, 2021, subject to continued service with the Company.
- [F4]The stock option vests in equal monthly installments over 48 months, beginning on April 8, 2021, subject to continued service to the Company.